iCarbonX
Founded Year
2015Stage
Series A - II | AliveTotal Raised
$199MLast Raised
$45M | 9 yrs agoAbout iCarbonX
iCarbonX leverages biological big data research for health management. The company integrates biological multi-omics research, data integration, and artificial intelligence (AI) driven analysis to develop solutions for preventative healthcare, disease diagnosis, treatment, and health maintenance. It serves the healthcare sector, offering products and applications to help individuals monitor and optimize health. It was founded in 2015 and is based in Shenzhen, China.
Loading...
Loading...
Expert Collections containing iCarbonX
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
iCarbonX is included in 3 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,276 items
Artificial Intelligence
12,302 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
11,408 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
iCarbonX Patents
iCarbonX has filed 1 patent.
The 3 most popular patent topics include:
- clusters of differentiation
- cytokines
- immune system
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/12/2021 | Transcription factors, Clusters of differentiation, Cytokines, Immune system, Immunology | Application |
Application Date | 3/12/2021 |
|---|---|
Grant Date | |
Title | |
Related Topics | Transcription factors, Clusters of differentiation, Cytokines, Immune system, Immunology |
Status | Application |
Latest iCarbonX News
Mar 5, 2025
Artificial Intelligence in Healthcare Market Growth Analysis: Size, Trends, and Future Outlook 2025-2033 The Latest research report offers an in-depth analysis of the Artificial Intelligence in Healthcare Market , highlighting key trends in product segmentation, company dynamics, revenue streams, market share, recent developments, and mergers & acquisitions. Additionally, it examines the strategies of leading global players, focusing on their Artificial Intelligence in Healthcare portfolios, core capabilities, market entry approaches, competitive positioning, and geographic presence. By doing so, this report provides valuable insights into how these companies navigate and thrive in the rapidly evolving Artificial Intelligence in Healthcare landscape. Artificial Intelligence in Healthcare Market , valued at USD 15482.79 million in 2025 is projected to reach USD 256534.28 million by 2033 with a CAGR of 41.5 % Who is the major manufacturers of Artificial Intelligence in Healthcare Market worldwide? Intel Corporation, Nvidia Corporation, Google, IBM Corporation, Microsoft Corporation, General Vision, Enlitic, Next IT, Welltok, Icarbonx, Recursion Pharmaceuticals, Koninklijke Philips, General Electric(GE) Company, Siemens Healthineers, Johnson & Johnson Services, Medtronic, Stryker Corporation, Careskore, Zephyr Health, Oncora Medical, Sentrian, Bay Labs, Atomwise, Deep Genomics, Cloudmedx This study also covers company profiling, specifications and product picture, sales, market share and contact information of various regional, international and local vendors of Artificial Intelligence in Healthcare Market. The market proposition is frequently developing ahead with the rise in scientific innovation and M&A activities in the industry. Additionally, many local and regional vendors are offering specific application products for varied end-users. The new merchant applicants in the market are finding it hard to compete with the international vendors based on reliability, quality and modernism in technology. Get More Info about Artificial Intelligence in Healthcare Market Report @ https://globalgrowthinsights.com/market-reports/artificial-intelligence-in-healthcare-market-104419 This Artificial Intelligence in Healthcare Market Research/Analysis Report Contains Answers to your following Questions What are the global trends in the Artificial Intelligence in Healthcare market? Would the market witness an increase or decline in the demand in the coming years? What is the estimated demand for different types of products in Artificial Intelligence in Healthcare? What are the upcoming industry applications and trends for the Artificial Intelligence in Healthcare market? What Are Projections of Global Artificial Intelligence in Healthcare Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export? Where will the strategic developments take the industry in the mid to long-term? What are the factors contributing to the final price of Artificial Intelligence in Healthcare? What are the raw materials used for Artificial Intelligence in Healthcare manufacturing? How big is the opportunity for the Artificial Intelligence in Healthcare market? How will the increasing adoption of Artificial Intelligence in Healthcare for mining impact the growth rate of the overall market? How much is the global Artificial Intelligence in Healthcare market worth? What was the value of the market In 2024? Who are the major players operating in the Artificial Intelligence in Healthcare market? Which companies are the front runners? Which are the recent industry trends that can be implemented to generate additional revenue streams? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Artificial Intelligence in Healthcare Industry? Contact Us:
iCarbonX Frequently Asked Questions (FAQ)
When was iCarbonX founded?
iCarbonX was founded in 2015.
Where is iCarbonX's headquarters?
iCarbonX's headquarters is located at Number 9018 Shennan Road, Nanshan District, Shenzhen.
What is iCarbonX's latest funding round?
iCarbonX's latest funding round is Series A - II.
How much did iCarbonX raise?
iCarbonX raised a total of $199M.
Who are the investors of iCarbonX?
Investors of iCarbonX include China Bridge Capital, Tencent, Vcanbio and Third Point Ventures.
Who are iCarbonX's competitors?
Competitors of iCarbonX include BioTwin and 1 more.
Loading...
Compare iCarbonX to Competitors
Banjo Health focuses on prior authorization automation within the healthcare sector. Its main offerings include a workflow platform that utilizes artificial intelligence to streamline the prior authorization process for medical and pharmacy benefits. The platform features decision trees for responses to prior authorization requests and tools for healthcare professionals to manage clinical criteria. Banjo Health serves health plans and pharmacy benefit managers. It was founded in 2019 and is based in Washington, District of Columbia.
Q Bio provides a healthcare platform. It offers a clinical digital twin platform designed to assess the medical history of patients. It develops the anatomical foundation model (AFM), an artificial intelligence (AI) model for whole-body radiology aimed at automating the analysis of scans and risk evaluation. It was founded in 2015 and is based in San Carlos, California.
Freenome focuses on early cancer detection through blood tests. The company's main offerings include next-generation blood tests that utilize multiomics technology and machine learning to identify cancer in its early stages. Freenome primarily serves the healthcare sector with a focus on improving cancer screening and detection. It was founded in 2014 and is based in Brisbane, California.
Twin Health provides personalized health programs for metabolic health within the healthcare sector. The company utilizes digital twin technology to model an individual's metabolism, alongside wearable devices and a clinical care team to address metabolic conditions. It serves employers and health plans, offering solutions for obesity, prediabetes, and type 2 diabetes. Twin Health was formerly known as Twins Digital. It was founded in 2018 and is based in Chennai, India.
BioTwin operates in the healthcare sector that utilizes AI and biomarker technology to develop virtual human models. Its offerings include virtual twins for early disease detection, prediction, and personalized preventive healthcare. BioTwin serves the healthcare industry by providing tools for clinical decision support and health surveillance. It was founded in 2018 and is based in Quebec City, Canada.
Quiver Bioscience specializes in creating CNS therapeutics and operates within the biotechnology sector. The company offers a platform that combines human disease models, artificial intelligence, and engineering to identify and develop therapeutic targets and candidate molecules for brain disorders. Quiver Bioscience primarily serves sectors focused on neurological disorder treatments and drug discovery. Quiver Bioscience was formerly known as Q-State Biosciences. It was founded in 2013 and is based in Cambridge, Massachusetts.
Loading...